Literature DB >> 10095107

Cloning, expression and chromosomal localization of a human testis 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene.

A Manzano1, J X Pérez, M Nadal, X Estivill, A Lange, R Bartrons.   

Abstract

6-Phosphofructo-2-kinase/fructose 2,6-bisphosphatase (PFK-2/FBPase-2) is a bifunctional enzyme responsible for the synthesis and breakdown of Fru-2,6-P2, a key metabolite in the regulation of glycolysis. Several genes encode distinct PFK-2/FBPase-2 isozymes that differ in their tissue distribution and enzyme regulation. In this paper, we present the isolation of a cDNA from a human testis cDNA library that encodes a PFK-2/FBPase-2 isozyme. Sequencing data show an open reading frame of 1407 nucleotides that codifies for a protein of 469 amino acids. This has a calculated molecular weight of 54kDa and 97% similarity with rat testis PFK-2/FBPase-2, with complete conservation of the amino acid residues involved in the catalytic mechanism. Fluorescence in-situ hybridization (FISH) localized testis PFK-2/FBPase-2 gene (PFKFB4) in human chromosome 3 at bands p21-p22. A Northern blot analysis of different rat tissues showed the presence of a 2.4-kb mRNA expressed specifically in testis. In mammalian COS-1 cells, the human testis cDNA drives expression of an isozyme with a molecular weight of 55kDa. This isozyme shows clear PFK-2 activity. Taken together, these results provide evidence for a new PFK-2/FBPase-2 gene coding for a human testis isozyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095107     DOI: 10.1016/s0378-1119(99)00037-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

Review 1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  Splice isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4: expression and hypoxic regulation.

Authors:  Oleksandr H Minchenko; Tsutomu Ogura; Iryna L Opentanova; Dmytro O Minchenko; Hiroyasu Esumi
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

Review 3.  Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.

Authors:  Brandon C Jones; Paula R Pohlmann; Robert Clarke; Surojeet Sengupta
Journal:  Cancer Metastasis Rev       Date:  2022-04-14       Impact factor: 9.237

4.  A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast.

Authors:  François Collard; Francesca Baldin; Isabelle Gerin; Jennifer Bolsée; Gaëtane Noël; Julie Graff; Maria Veiga-da-Cunha; Vincent Stroobant; Didier Vertommen; Amina Houddane; Mark H Rider; Carole L Linster; Emile Van Schaftingen; Guido T Bommer
Journal:  Nat Chem Biol       Date:  2016-06-13       Impact factor: 15.040

5.  Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.

Authors:  Jason Chesney; Jennifer Clark; Alden C Klarer; Yoannis Imbert-Fernandez; Andrew N Lane; Sucheta Telang
Journal:  Oncotarget       Date:  2014-08-30

Review 6.  Fructose 2,6-Bisphosphate in Cancer Cell Metabolism.

Authors:  Ramon Bartrons; Helga Simon-Molas; Ana Rodríguez-García; Esther Castaño; Àurea Navarro-Sabaté; Anna Manzano; Ubaldo E Martinez-Outschoorn
Journal:  Front Oncol       Date:  2018-09-04       Impact factor: 6.244

7.  Skeletal muscle transcriptome in healthy aging.

Authors:  Robert A Tumasian; Abhinav Harish; Gautam Kundu; Jen-Hao Yang; Ceereena Ubaida-Mohien; Marta Gonzalez-Freire; Mary Kaileh; Linda M Zukley; Chee W Chia; Alexey Lyashkov; William H Wood; Yulan Piao; Christopher Coletta; Jun Ding; Myriam Gorospe; Ranjan Sen; Supriyo De; Luigi Ferrucci
Journal:  Nat Commun       Date:  2021-04-01       Impact factor: 14.919

8.  Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells.

Authors:  Charlotte Taylor; David Mannion; Fabrizio Miranda; Mohammad Karaminejadranjbar; Sandra Herrero-Gonzalez; Karin Hellner; Yiyan Zheng; Geoffrey Bartholomeusz; Robert C Bast; Ahmed Ashour Ahmed
Journal:  Oncotarget       Date:  2017-03-14

9.  Phosphofructokinases Axis Controls Glucose-Dependent mTORC1 Activation Driven by E2F1.

Authors:  Eugènia Almacellas; Joffrey Pelletier; Anna Manzano; Antonio Gentilella; Santiago Ambrosio; Caroline Mauvezin; Albert Tauler
Journal:  iScience       Date:  2019-10-01

10.  PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer.

Authors:  Yu-Chen Cai; Hang Yang; Hong-Bo Shan; Hui-Fang Su; Wen-Qi Jiang; Yan-Xia Shi
Journal:  Dis Markers       Date:  2021-06-09       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.